Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

RG1-VLP and Other L2-Based, Broad-Spectrum HPV Vaccine Candidates
Bettina Huber, Joshua Weiyuan Wang, Richard B.S. Roden, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 5, pp. 1044-1044
Open Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

Virus-like particle vaccinology, from bench to bedside
Mona O. Mohsen, Martin F. Bachmann
Cellular and Molecular Immunology (2022) Vol. 19, Iss. 9, pp. 993-1011
Open Access | Times Cited: 155
Prophylactic and Therapeutic HPV Vaccines: Current Scenario and Perspectives
Yicheng Mo, Jiabing Ma, Hongtao Zhang, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 96
The future of cancer immunotherapy: DNA vaccines leading the way
Aanshi J. Pandya, Yesha Shah, Nirjari Kothari, et al.
Medical Oncology (2023) Vol. 40, Iss. 7
Open Access | Times Cited: 45
HPV Infections—Classification, Pathogenesis, and Potential New Therapies
Beata Mlynarczyk-Bonikowska, Lidia Rudnicka
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7616-7616
Open Access | Times Cited: 18
Prophylactic vaccines against HPV-caused cervical cancer: novel vaccines are still demanded
Sogand Amiri, Shiva Rasekh, Seyed Mohammad Iman Moezzi, et al.
Infectious Agents and Cancer (2025) Vol. 20, Iss. 1
Open Access | Times Cited: 2
Virus-like Particles as Preventive and Therapeutic Cancer Vaccines
Anna Lucia Tornesello, Maria Tagliamonte, Franco M. Buonaguro, et al.
Vaccines (2022) Vol. 10, Iss. 2, pp. 227-227
Open Access | Times Cited: 67
Prophylactic Human Papillomavirus Vaccination: From the Origin to the Current State
Ayazhan Akhatova, Azliyati Azizan, Kuralay Atageldiyeva, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1912-1912
Open Access | Times Cited: 46
Rational design of a triple-type HPV53/56/66 vaccine with one preferable base particle incorporating two identified immunodominant sites
Ciying Qian, Jie Chen, Yurou Yang, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
HPV vaccination and HPV-related malignancies: impact, strategies and optimizations toward global immunization coverage
Gaia Giannone, Anna R. Giuliano, Marco Bandini, et al.
Cancer Treatment Reviews (2022) Vol. 111, pp. 102467-102467
Closed Access | Times Cited: 36
A safe and potentiated multi-type HPV L2-E7 nanoparticle vaccine with combined prophylactic and therapeutic activity
Xueer Zhao, Yueru Zhang, Óscar Trejo-Cerro, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 7
Widespread Horizontal Gene Transfer Among Animal Viruses
Christopher B. Buck, Nicole L. Welch, Anna K. Belford, et al.
(2024)
Open Access | Times Cited: 6
Harnessing Nanovaccines for Effective Immunization─A Special Concern on COVID-19: Facts, Fidelity, and Future Prospective
Amol D. Gholap, Juhi Gupta, Pallavi Kamandar, et al.
ACS Biomaterials Science & Engineering (2023) Vol. 10, Iss. 1, pp. 271-297
Closed Access | Times Cited: 13
Vaccine escape challenges virus prevention: The example of two vaccine‐preventable oncogenic viruses
Wenjie Qu, Long Sui, Yanyun Li
Journal of Medical Virology (2023) Vol. 95, Iss. 11
Open Access | Times Cited: 10
Virus-like particles: Innovative strategies for combatting emerging and re-emerging viral threats
Bugude Laxmi, P. Uma Maheswari Devi, Naveen Thanjavur, et al.
The Microbe (2025), pp. 100351-100351
Open Access
Human Papillomaviruses
Adriana Cadilla, Linette Sande, Kenneth Alexander
Elsevier eBooks (2025), pp. 1414-1429.e8
Closed Access
New Perspectives in Therapeutic Vaccines for HPV: A Critical Review
Bárbara Gardella, Andrea Gritti, Ehsan Soleymaninejadian, et al.
Medicina (2022) Vol. 58, Iss. 7, pp. 860-860
Open Access | Times Cited: 15
Mutation Profile of HPV16 L1 and L2 Genes in Different Geographic Areas
D. Tsakogiannis, Marios Nikolaidis, Flora Zagouri, et al.
Viruses (2022) Vol. 15, Iss. 1, pp. 141-141
Open Access | Times Cited: 15
Widespread Horizontal Gene Transfer Among Animal Viruses
Christopher B. Buck, Nicole L. Welch, Anna K. Belford, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Human Papillomavirus and Cervical Cancer: A Narrative Review
Abolfazl Jafari-Sales, Kosar Hosseini-Karkaj, Kosar Soleymanpour, et al.
Modern Care Journal (2025) Vol. 22, Iss. 2
Open Access
Next generation L2-based HPV vaccines cross-protect against cutaneous papillomavirus infection and tumor development
Melinda Ahmels, Filipe Colaço Mariz, Ilona Braspenning‐Wesch, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 14
A respirable HPV-L2 dry-powder vaccine with GLA as amphiphilic lubricant and immune-adjuvant
Irene Rossi, Gloria Spagnoli, Francesca Buttini, et al.
Journal of Controlled Release (2021) Vol. 340, pp. 209-220
Closed Access | Times Cited: 17
Prevention and Treatment of HPV-Induced Skin Tumors
Daniel Hasche, Baki Akgül
Cancers (2023) Vol. 15, Iss. 6, pp. 1709-1709
Open Access | Times Cited: 7
Cervical Human Papillomavirus Infection (HPV) and High Oncogenic Risk Genotypes among Women Living with HIV in Asia: A Meta-Analysis
Florian Verrier, Sophie Le Cœur, Tristan Delory
Journal of Clinical Medicine (2021) Vol. 10, Iss. 9, pp. 1911-1911
Open Access | Times Cited: 12
A bacterially expressed triple-type chimeric vaccine against human papillomavirus types 51, 69, and 26
Miao Yu, Xin Chi, Shiwen Huang, et al.
Vaccine (2022) Vol. 40, Iss. 42, pp. 6141-6152
Open Access | Times Cited: 9
Human Papillomavirus Vaccines
John T. Schiller, Lauri E. Markowitz, Aimée R. Kreimer, et al.
Elsevier eBooks (2023), pp. 484-513.e11
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top